John Lechleiter - Facts About Menopause

Eli Lilly & Co. said Tuesday it will not seek Food and Drug Administration approval for its developing postmenopausal osteoporosis drug because of certain study results and safety concerns.The company said the drug met its late-stage study goals of reducing the risk ...